Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Active Ankylosing Spondylitis (RHAPSODY)
NCT00478660Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2006
- Modality
- Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 3 trial of adalimumab in ankylosing spondylitis (AS), sponsored by Abbott Laboratories. Started Feb 2006; status: completed.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00478660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478660.